Labcorp — Feb 17, 2026 release

• Announced a strategic investment to build a new state-of-the-art 500,000 square foot Central Laboratory facility in Indiana, with construction expected to begin later in 2026. On January 14, 2026, the company announced a quarterly cash dividend of $0.72 per share of common stock, payable on March 12, 2026, to stockholders of record at the close of business on February 27, 2026. In the quarter, Labcorp repurchased $225 million of common stock, resulting in full year total share repurchase of $450 million. 2 LABCORP HOLDINGS INC. AND SUBSIDIARIES CONSOLIDATED RESULTS Three Months Ended Dec 31, Year Ended Dec 31, 2025 2024 Delta 2025 2024 Delta Revenue Summary (Dollars in billions) Total Revenue $ 3.52  $ 3.33  5.6 % $ 13.95  $ 13.01  7.2 % Organic (1) 3.8 % 4.4 % Acquisitions, net of Divestitures 1.2 % 2.5 % Foreign Exchange 0.6 % 0.4 % (1) Organic revenue is no longer separated between the Base Business and COVID-19 Testing. Earnings Summary (Dollars in millions, except per share data) Operating Income (“OI”) $ 267.6  $ 216.5  $ 1,384.7  $ 1,086.7  OI as % of Revenue 7.6  % 6.5  % 110 bps 9.9  % 8.4  % 160 bps Adjustments (2) $ 220.1  $ 206.7  $ 616.9  $ 710.3  Adjusted Operating Income (“AOI”) (3) $ 487.7  (4) $ 423.2  $ 2,001.6  $ 1,797.0  AOI as % of Revenue 13.9  % (4) 12.7  % 120 bps 14.3  % 13.8  % 50 bps Net Earnings Attributable to Labcorp Holdings Inc. $ 164.7  $ 143.4  $ 876.5  $ 746.0  Diluted EPS $ 1.98  $ 1.70  $ 10.46  $ 8.84